content ed net

GLOBAL SITE 資料請求

Published Articles

List of published articles

  • Evaluation of combination treatment with DS‑1205c, an AXL kinase inhibitor, and osimertinib in metastatic or unresectable EGFR‑mutant non‑small cell lung cancer: results from a multicenter, open‑label phase 1 study

    Source: Invest New Drugs. 2023 Apr;41(2):306-316.
    DOI: https://link.springer.com/article/10.1007/s10637-023-01341-y

  • Phase 1 study of DS-1205c combined with gefitinib for EGFR mutation-positive non-small cell lung cancer

    Source: Cancer Med. 2023 Mar;12(6):7090-7104.
    DOI: https://onlinelibrary.wiley.com/doi/full/10.1002/cam4.5508